Cell and Gene Therapy Manufacturing QC Market Size & Growth Analysis

Download Free Sample

Market Segmentation

Cell and Gene Therapy Manufacturing QC Market, By Therapy Type (2020-2032)

Cell Therapy
1. CAR-T
  1. Autologous CAR-T
  2. Allogeneic CAR-T
2. CAR-NK
  1. B-Cell
  2. Other
Gene Therapy
1. Viral
  1. AAV
  2. Lentiviral vectors
  3. Other
2. Non-Viral

Cell and Gene Therapy Manufacturing QC Market, By Scale (2020-2032)

Pre-commercial/ R&D Manufacturing
Commercial Scale Manufacturing

Cell and Gene Therapy Manufacturing QC Market, By Mode (2020-2032)

Contract Manufacturing
In-house Manufacturing

Cell and Gene Therapy Manufacturing QC Market, By Workflow (2020-2032)

Cell Processing
Cell Banking
Fill & Finish Operations
Raw Material Testing
Vector Production
Other Workflows

Cell and Gene Therapy Manufacturing QC Market, By Process (2020-2032)

Upstream Processes
Downstream Processes

Cell and Gene Therapy Manufacturing QC Market, By End-User (2020-2032)

Pharmaceutical Companies
1. Small Size
2. Medium Size
3. Large Size
Biopharmaceutical / Biotechnological Companies
1. Small Size
2. Medium Size
3. Large Size
Contract Manufacturing Organizations
1. Small Size
2. Medium Size
3. Large Size

Cell and Gene Therapy Manufacturing QC Market, By Technology Type (2020-2032)

Fluorescence-Activated Cell Sorting (FACS)
Enzyme-Linked Immunosorbent Assay (ELISA)
Chromatography
Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Others

Regional Cell and Gene Therapy Manufacturing QC Market

North America
1. North America Cell and Gene Therapy Manufacturing QC Market, By Therapy Type
  1. Cell Therapy
  2. Gene Therapy
2. North America Cell and Gene Therapy Manufacturing QC Market, By Scale
  1. Pre-commercial/ R&D Manufacturing
  2. Commercial Scale Manufacturing
3. North America Cell and Gene Therapy Manufacturing QC Market, By Mode
  1. Contract Manufacturing
  2. In-house Manufacturing
4. North America Cell and Gene Therapy Manufacturing QC Market, By Workflow
  1. Cell Processing
  2. Cell Banking
  3. Fill & Finish Operations
  4. Raw Material Testing
  5. Vector Production
  6. Other Workflows
5. North America Cell and Gene Therapy Manufacturing QC Market, By Process
  1. Upstream Processes
  2. Downstream Processes
6. North America Cell and Gene Therapy Manufacturing QC Market, By End-User
  1. Pharmaceutical Companies
  2. Biopharmaceutical / Biotechnological Companies
  3. Contract Manufacturing Organizations
7. North America Cell and Gene Therapy Manufacturing QC Market, By Technology Type
  1. Fluorescence-Activated Cell Sorting (FACS)
  2. Enzyme-Linked Immunosorbent Assay (ELISA)
  3. Chromatography
  4. Next-Generation Sequencing (NGS)
  5. Polymerase Chain Reaction (PCR)
  6. Others
8. U.S.
  1. U.S. Cell and Gene Therapy Manufacturing QC Market, By Therapy Type
    1. Cell Therapy
    2. Gene Therapy
  2. U.S. Cell and Gene Therapy Manufacturing QC Market, By Scale
    1. Pre-commercial/ R&D Manufacturing
    2. Commercial Scale Manufacturing
  3. U.S. Cell and Gene Therapy Manufacturing QC Market, By Mode
    1. Contract Manufacturing
    2. In-house Manufacturing
  4. U.S. Cell and Gene Therapy Manufacturing QC Market, By Workflow
    1. Cell Processing
    2. Cell Banking
    3. Fill & Finish Operations
    4. Raw Material Testing
    5. Vector Production
    6. Other Workflows
  5. U.S. Cell and Gene Therapy Manufacturing QC Market, By Process
    1. Upstream Processes
    2. Downstream Processes
  6. U.S. Cell and Gene Therapy Manufacturing QC Market, By End-User
    1. Pharmaceutical Companies
    2. Biopharmaceutical / Biotechnological Companies
    3. Contract Manufacturing Organizations
  7. U.S. Cell and Gene Therapy Manufacturing QC Market, By Technology Type
    1. Fluorescence-Activated Cell Sorting (FACS)
    2. Enzyme-Linked Immunosorbent Assay (ELISA)
    3. Chromatography
    4. Next-Generation Sequencing (NGS)
    5. Polymerase Chain Reaction (PCR)
    6. Others
9. Canada
Europe
1. Europe Cell and Gene Therapy Manufacturing QC Market, By Therapy Type
  1. Cell Therapy
  2. Gene Therapy
2. Europe Cell and Gene Therapy Manufacturing QC Market, By Scale
  1. Pre-commercial/ R&D Manufacturing
  2. Commercial Scale Manufacturing
3. Europe Cell and Gene Therapy Manufacturing QC Market, By Mode
  1. Contract Manufacturing
  2. In-house Manufacturing
4. Europe Cell and Gene Therapy Manufacturing QC Market, By Workflow
  1. Cell Processing
  2. Cell Banking
  3. Fill & Finish Operations
  4. Raw Material Testing
  5. Vector Production
  6. Other Workflows
5. Europe Cell and Gene Therapy Manufacturing QC Market, By Process
  1. Upstream Processes
  2. Downstream Processes
6. Europe Cell and Gene Therapy Manufacturing QC Market, By End-User
  1. Pharmaceutical Companies
  2. Biopharmaceutical / Biotechnological Companies
  3. Contract Manufacturing Organizations
7. Europe Cell and Gene Therapy Manufacturing QC Market, By Technology Type
  1. Fluorescence-Activated Cell Sorting (FACS)
  2. Enzyme-Linked Immunosorbent Assay (ELISA)
  3. Chromatography
  4. Next-Generation Sequencing (NGS)
  5. Polymerase Chain Reaction (PCR)
  6. Others
8. U.K.
  1. U.K. Cell and Gene Therapy Manufacturing QC Market, By Therapy Type
    1. Cell Therapy
    2. Gene Therapy
  2. U.K. Cell and Gene Therapy Manufacturing QC Market, By Scale
    1. Pre-commercial/ R&D Manufacturing
    2. Commercial Scale Manufacturing
  3. U.K. Cell and Gene Therapy Manufacturing QC Market, By Mode
    1. Contract Manufacturing
    2. In-house Manufacturing
  4. U.K. Cell and Gene Therapy Manufacturing QC Market, By Workflow
    1. Cell Processing
    2. Cell Banking
    3. Fill & Finish Operations
    4. Raw Material Testing
    5. Vector Production
    6. Other Workflows
  5. U.K. Cell and Gene Therapy Manufacturing QC Market, By Process
    1. Upstream Processes
    2. Downstream Processes
  6. U.K. Cell and Gene Therapy Manufacturing QC Market, By End-User
    1. Pharmaceutical Companies
    2. Biopharmaceutical / Biotechnological Companies
    3. Contract Manufacturing Organizations
  7. U.K. Cell and Gene Therapy Manufacturing QC Market, By Technology Type
    1. Fluorescence-Activated Cell Sorting (FACS)
    2. Enzyme-Linked Immunosorbent Assay (ELISA)
    3. Chromatography
    4. Next-Generation Sequencing (NGS)
    5. Polymerase Chain Reaction (PCR)
    6. Others
9. Germany
10. France
11. Spain
12. Italy
13. Russia
14. Nordic
15. Benelux
16. Rest of Europe
APAC
1. APAC Cell and Gene Therapy Manufacturing QC Market, By Therapy Type
  1. Cell Therapy
  2. Gene Therapy
2. APAC Cell and Gene Therapy Manufacturing QC Market, By Scale
  1. Pre-commercial/ R&D Manufacturing
  2. Commercial Scale Manufacturing
3. APAC Cell and Gene Therapy Manufacturing QC Market, By Mode
  1. Contract Manufacturing
  2. In-house Manufacturing
4. APAC Cell and Gene Therapy Manufacturing QC Market, By Workflow
  1. Cell Processing
  2. Cell Banking
  3. Fill & Finish Operations
  4. Raw Material Testing
  5. Vector Production
  6. Other Workflows
5. APAC Cell and Gene Therapy Manufacturing QC Market, By Process
  1. Upstream Processes
  2. Downstream Processes
6. APAC Cell and Gene Therapy Manufacturing QC Market, By End-User
  1. Pharmaceutical Companies
  2. Biopharmaceutical / Biotechnological Companies
  3. Contract Manufacturing Organizations
7. APAC Cell and Gene Therapy Manufacturing QC Market, By Technology Type
  1. Fluorescence-Activated Cell Sorting (FACS)
  2. Enzyme-Linked Immunosorbent Assay (ELISA)
  3. Chromatography
  4. Next-Generation Sequencing (NGS)
  5. Polymerase Chain Reaction (PCR)
  6. Others
8. China
  1. China Cell and Gene Therapy Manufacturing QC Market, By Therapy Type
    1. Cell Therapy
    2. Gene Therapy
  2. China Cell and Gene Therapy Manufacturing QC Market, By Scale
    1. Pre-commercial/ R&D Manufacturing
    2. Commercial Scale Manufacturing
  3. China Cell and Gene Therapy Manufacturing QC Market, By Mode
    1. Contract Manufacturing
    2. In-house Manufacturing
  4. China Cell and Gene Therapy Manufacturing QC Market, By Workflow
    1. Cell Processing
    2. Cell Banking
    3. Fill & Finish Operations
    4. Raw Material Testing
    5. Vector Production
    6. Other Workflows
  5. China Cell and Gene Therapy Manufacturing QC Market, By Process
    1. Upstream Processes
    2. Downstream Processes
  6. China Cell and Gene Therapy Manufacturing QC Market, By End-User
    1. Pharmaceutical Companies
    2. Biopharmaceutical / Biotechnological Companies
    3. Contract Manufacturing Organizations
  7. China Cell and Gene Therapy Manufacturing QC Market, By Technology Type
    1. Fluorescence-Activated Cell Sorting (FACS)
    2. Enzyme-Linked Immunosorbent Assay (ELISA)
    3. Chromatography
    4. Next-Generation Sequencing (NGS)
    5. Polymerase Chain Reaction (PCR)
    6. Others
9. Korea
10. Japan
11. India
12. Australia
13. Taiwan
14. South East Asia
15. Rest of Asia-Pacific
Middle East and Africa
1. Middle East and Africa Cell and Gene Therapy Manufacturing QC Market, By Therapy Type
  1. Cell Therapy
  2. Gene Therapy
2. Middle East and Africa Cell and Gene Therapy Manufacturing QC Market, By Scale
  1. Pre-commercial/ R&D Manufacturing
  2. Commercial Scale Manufacturing
3. Middle East and Africa Cell and Gene Therapy Manufacturing QC Market, By Mode
  1. Contract Manufacturing
  2. In-house Manufacturing
4. Middle East and Africa Cell and Gene Therapy Manufacturing QC Market, By Workflow
  1. Cell Processing
  2. Cell Banking
  3. Fill & Finish Operations
  4. Raw Material Testing
  5. Vector Production
  6. Other Workflows
5. Middle East and Africa Cell and Gene Therapy Manufacturing QC Market, By Process
  1. Upstream Processes
  2. Downstream Processes
6. Middle East and Africa Cell and Gene Therapy Manufacturing QC Market, By End-User
  1. Pharmaceutical Companies
  2. Biopharmaceutical / Biotechnological Companies
  3. Contract Manufacturing Organizations
7. Middle East and Africa Cell and Gene Therapy Manufacturing QC Market, By Technology Type
  1. Fluorescence-Activated Cell Sorting (FACS)
  2. Enzyme-Linked Immunosorbent Assay (ELISA)
  3. Chromatography
  4. Next-Generation Sequencing (NGS)
  5. Polymerase Chain Reaction (PCR)
  6. Others
8. UAE
  1. UAE Cell and Gene Therapy Manufacturing QC Market, By Therapy Type
    1. Cell Therapy
    2. Gene Therapy
  2. UAE Cell and Gene Therapy Manufacturing QC Market, By Scale
    1. Pre-commercial/ R&D Manufacturing
    2. Commercial Scale Manufacturing
  3. UAE Cell and Gene Therapy Manufacturing QC Market, By Mode
    1. Contract Manufacturing
    2. In-house Manufacturing
  4. UAE Cell and Gene Therapy Manufacturing QC Market, By Workflow
    1. Cell Processing
    2. Cell Banking
    3. Fill & Finish Operations
    4. Raw Material Testing
    5. Vector Production
    6. Other Workflows
  5. UAE Cell and Gene Therapy Manufacturing QC Market, By Process
    1. Upstream Processes
    2. Downstream Processes
  6. UAE Cell and Gene Therapy Manufacturing QC Market, By End-User
    1. Pharmaceutical Companies
    2. Biopharmaceutical / Biotechnological Companies
    3. Contract Manufacturing Organizations
  7. UAE Cell and Gene Therapy Manufacturing QC Market, By Technology Type
    1. Fluorescence-Activated Cell Sorting (FACS)
    2. Enzyme-Linked Immunosorbent Assay (ELISA)
    3. Chromatography
    4. Next-Generation Sequencing (NGS)
    5. Polymerase Chain Reaction (PCR)
    6. Others
9. Turkey
10. Saudi Arabia
11. South Africa
12. Egypt
13. Nigeria
14. Rest of MEA
LATAM
1. LATAM Cell and Gene Therapy Manufacturing QC Market, By Therapy Type
  1. Cell Therapy
  2. Gene Therapy
2. LATAM Cell and Gene Therapy Manufacturing QC Market, By Scale
  1. Pre-commercial/ R&D Manufacturing
  2. Commercial Scale Manufacturing
3. LATAM Cell and Gene Therapy Manufacturing QC Market, By Mode
  1. Contract Manufacturing
  2. In-house Manufacturing
4. LATAM Cell and Gene Therapy Manufacturing QC Market, By Workflow
  1. Cell Processing
  2. Cell Banking
  3. Fill & Finish Operations
  4. Raw Material Testing
  5. Vector Production
  6. Other Workflows
5. LATAM Cell and Gene Therapy Manufacturing QC Market, By Process
  1. Upstream Processes
  2. Downstream Processes
6. LATAM Cell and Gene Therapy Manufacturing QC Market, By End-User
  1. Pharmaceutical Companies
  2. Biopharmaceutical / Biotechnological Companies
  3. Contract Manufacturing Organizations
7. LATAM Cell and Gene Therapy Manufacturing QC Market, By Technology Type
  1. Fluorescence-Activated Cell Sorting (FACS)
  2. Enzyme-Linked Immunosorbent Assay (ELISA)
  3. Chromatography
  4. Next-Generation Sequencing (NGS)
  5. Polymerase Chain Reaction (PCR)
  6. Others
8. Brazil
  1. Brazil Cell and Gene Therapy Manufacturing QC Market, By Therapy Type
    1. Cell Therapy
    2. Gene Therapy
  2. Brazil Cell and Gene Therapy Manufacturing QC Market, By Scale
    1. Pre-commercial/ R&D Manufacturing
    2. Commercial Scale Manufacturing
  3. Brazil Cell and Gene Therapy Manufacturing QC Market, By Mode
    1. Contract Manufacturing
    2. In-house Manufacturing
  4. Brazil Cell and Gene Therapy Manufacturing QC Market, By Workflow
    1. Cell Processing
    2. Cell Banking
    3. Fill & Finish Operations
    4. Raw Material Testing
    5. Vector Production
    6. Other Workflows
  5. Brazil Cell and Gene Therapy Manufacturing QC Market, By Process
    1. Upstream Processes
    2. Downstream Processes
  6. Brazil Cell and Gene Therapy Manufacturing QC Market, By End-User
    1. Pharmaceutical Companies
    2. Biopharmaceutical / Biotechnological Companies
    3. Contract Manufacturing Organizations
  7. Brazil Cell and Gene Therapy Manufacturing QC Market, By Technology Type
    1. Fluorescence-Activated Cell Sorting (FACS)
    2. Enzyme-Linked Immunosorbent Assay (ELISA)
    3. Chromatography
    4. Next-Generation Sequencing (NGS)
    5. Polymerase Chain Reaction (PCR)
    6. Others
9. Mexico
10. Argentina
11. Chile
12. Colombia
13. Rest of LATAM

Related Reports

Cell and Gene Therapy Market

Global Report

Cell and Gene Therapy Market Size The global cell and gene therapy market size was valued at USD 30.27 billion in 2024 and is projected to reach from USD 37.14 billion in 2025 to USD 190.82 billion by 2033, expanding at a CAGR of 22.7% from 2025 to

Buy Now

Purchase Benefits

Eligible for a free updated report next year
Completely customizable scope
30% discount on your next purchase
Dedicated account manager
Query resolution within 24 hours
Permission to print the report

Market Segmentation

Related Reports

Purchase Benefits

We are featured on :

Sample Details